represents decreasing of 34 Million Baht (2,642%) from Q1/2017. The main cause for the lower net profit is economic in Thailand just recovery, and there is a delayed effect before reaching down to

ended December 31, 2018. The Group's sales and net profit totaled Bt13,982.5 million and Bt2,014.9 million, respectively, compared to Bt14,195.4 million and Bt2,544.5 million in fiscal year 2017. A

operating performance of the company more than 20% as follow: Revenue Total Revenue of the Company and subsidiaries for Year ended December 31, 2019 when comparing with the year 2018 increased from THB 333.40

auditor as follows: Separate financial statements The Company reported profit for Q2/2017 in the amount of Baht 307.2 million (Q2/2016 : Baht 251.0 million) which increased in the amount of Baht 56.2

independent auditor as follows: Consolidated financial statements The Company reported profit for Q3/2017 in the amount of Baht 365.6 million (Q3/2016 : Baht 292.8 million) which increased in the amount of Baht

212.50 191.39 -21.12 -9.94 -20.77 -9.79 844.32 820.92 -23.41 -2.77 Cost of Goods Sold 181.91 194.11 180.66 -13.45 -6.93 -1.25 -0.69 713.01 745.72 32.71 4.59 Gross Profit Margin 30.25 18.39 10.73 -7.66

audited by the independent auditor as follows: Consolidated financial statements The Company reported profit for the year 2017 in the amount of Baht 1,118.6 million (2016 : Baht 932.8 million) which

for the amount of THB 28.6 million. The net amount after amortization was 25.0 million in the first 9-month period of 2017 Revenue from Hospital Operations Revenue from hospital operations in the third

1,820.49 Distribution Expense 63.21 50.30 Administrative Expense 59.70 73.65 Finance Costs 21.95 24.29 Net Profit 271.25 32.34 Earnings per share (Baht) 0.679 0.081 The comparison between Second Quarter of

(expenses) income (7,423) 0.74% 1,525 0.18% (8,948) 586.75% Profit (loss) for the period 112,695 11.29% 100,337 11.84% 12,358 12.32% Remark: Financial ratio is based on common-size analysis to total revenue